Skip to main content
. 2020 Jun;21(6):1637–1644. doi: 10.31557/APJCP.2020.21.6.1637

Table 6.

GSTT1, GSTM1, A313G GSTP1 and C341T GSTP1 Polymorphisms in Relation to Recurrence and Survival of Patients with Head and Neck Cancer

Polymorphisms Relapse (12 months) P- value Log Rank Survival (12 months) P- value Log Rank
GSTT1
Positive 23.0% 0.467 85.0% 0.135
Negative 30.0% 72.0%
GSTM1
Positive 26.0% 0.717 85.0% 0.314
Negative 22.0% 80.0%
A313G GSTP1
AA 24.0% 0.450 78.0% 0.487
AG/GG 23.0% 88.0%
C341T GSTP1
CC 25.0% 0.164 83.0% 0.566
CT/TT 12.0% 82.0%